Research Paper Volume 15, Issue 24 pp 15025—15049
The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis
Figure 4. Forest plot of all-grade (A) and high-grade (B) TRAEs in NSCLC patients treated with ICIs versus non-ICIs. CI, confidence interval; TRAEs, treatment-related adverse events; ICIs, immune checkpoint inhibitors.